Position in MDXG
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,050,397
+$974,784 QoQ
Shares Held
792,311
+50.8% QoQ
Ownership
0.544%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 226 holders
Holding Since
Jun 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Derivatives in MDXG
reported options exposure · as of Mar 31, 2026CallValue
$62,015
CallShares
15,700
PutValue
$164,715
PutShares
41,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. MDXG ranks #48 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in MDXG
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,050,397 | 792,311 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $164,715 | 41,700 | Put | Defined | 2026-05-12 | |
| 2026-03-31 | $2,075,613 | 525,472 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $62,015 | 15,700 | Call | Defined | 2026-05-12 | |
| 2025-12-31 | $104,935 | 15,500 | Call | Defined | 2026-02-12 | |
| 2025-12-31 | $1,755,202 | 259,262 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $124,568 | 18,400 | Put | Defined | 2026-02-12 | |
| 2025-09-30 | $1,809,661 | 259,264 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $208,702 | 29,900 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $256,864 | 36,800 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $146,029 | 23,900 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,872,793 | 306,513 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $146,029 | 23,900 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,796,616 | 236,397 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $3,709,413 | 385,594 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,806,402 | 305,652 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $906,824 | 130,855 | Shares | Defined | 2024-08-15 | |
| 2024-03-31 | $540,547 | 70,201 | Shares | Defined | 2024-05-16 | |
| 2023-12-31 | $648,434 | 73,938 | Shares | Defined | 2024-02-15 | |
| 2023-06-30 | $471,742 | 71,368 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $202,243 | 59,309 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $181,837 | 65,409 | Shares | Defined | 2023-02-15 | |
| 2022-03-31 | $144,968 | 30,779 | Shares | Defined | 2022-05-17 | |
| 2022-03-31 | $122,460 | 26,000 | Call | Defined | 2022-05-17 | |
| 2021-12-31 | $681,916 | 112,900 | Call | Defined | 2022-02-15 | |
| 2021-12-31 | $169,724 | 28,100 | Put | Defined | 2022-02-15 | |
| 2021-12-31 | $133,380 | 22,083 | Shares | Defined | 2022-02-15 | |
| 2021-09-30 | $513,348 | 84,711 | Shares | Defined | 2021-11-16 | |
| 2021-09-30 | $169,680 | 28,000 | Put | Defined | 2021-11-16 | |
| 2021-09-30 | $661,752 | 109,200 | Call | Defined | 2021-11-16 | |
| 2021-06-30 | $156,375 | 12,500 | Call | Defined | 2021-08-16 | |
| 2021-06-30 | $1,208,715 | 96,620 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||